High density lipoprotein (HDL), the carrier of so-called "good" cholesterol, serves as the major athero-protective lipoprotein and has emerged as a key therapeutic target for cardiovascular disease. We applied small angle neutron scattering (SANS) with contrast variation and selective isotopic deuteration to the study of nascent HDL to obtain the low resolution structure in solution of the overall time-averaged conformation of apolipoprotein AI (apoA-I) versus the lipid (acyl chain) core of the particle. Remarkably, apoA-I is observed to possess an open helical shape that wraps around a central ellipsoidal lipid phase. Using the low resolution SANS shapes of the protein and lipid core as scaffolding, an all-atom computational model for the protein and lipid components of nascent HDL was developed by integrating complementary structural data from hydrogen/deuterium exchange mass spectrometry and previously published constraints from multiple biophysical techniques. Both SANS data and the new computational model, the double superhelix model, suggest an unexpected structural arrangement of protein and lipids of nascent HDL, an anti-parallel double superhelix wrapped around an ellipsoidal lipid phase. The protein and lipid organization in nascent HDL envisages a potential generalized mechanism for lipoprotein biogenesis and remodeling, biological processes critical to sterol and lipid transport, organismal energy metabolism, and innate immunity.
High density lipoprotein (HDL)2 functions in removal of cholesterol from peripheral tissues, such as within the artery wall, for delivery to the liver and ultimate excretion as biliary cholesterol within the intestinal lumen, a process called reverse cholesterol transport (1, 2). Plasma levels of HDL cholesterol and apolipoprotein AI (apoA-I), the major protein component of HDL, are inversely related to the risk of developing coronary artery disease (3-5). Moreover, genetic alterations that induce changes in apoA-I levels in both animals and humans alter susceptibility for development of atherosclerotic heart disease (3-6). Thus, numerous interventions aimed at enhancing reverse cholesterol transport are being examined as potential novel therapeutic interventions for the prevention and treatment of cardiovascular disease (7,8). Examples include methods for generating new HDL particles through enhanced production or delivery of either intact apoA-I (9, 10) or peptide mimetics of apoA-I (11), as well as modulating interactions between nascent HDL and proteins involved in HDL particle maturation and remodeling for potential therapeutic benefit (12-14). Structural elucidation often serves as the "Rosetta Stone" for enhanced understanding of function. It is thus remarkable that despite its importance to numerous biological and biomedical functions and its current prominent role as a target for therapeutic interventions, to date, the structures of neither the protein nor lipid components of nascent HDL have been directly visualized, and the high resolution structure of the particl...